LA, R. C., A, K., L, C. d. O., JS, M., JC, S., E, C., . . . RJ, G. (2023). Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display. PLoS neglected tropical diseases, 17(1), e0011019. https://doi.org/10.1371/journal.pntd.0011019
Chicago Style (17th ed.) CitationLA, Rodriguez Carnero, Kuramoto A, Campos de Oliveira L, Monteiro JS, Setubal JC, Cunha-Neto E, Cerdeira Sabino E, and Giordano RJ. "Anti-Trypanosoma Cruzi Antibody Profiling in Patients with Chagas Disease Treated with Benznidazole Assessed by Genome Phage Display." PLoS Neglected Tropical Diseases 17, no. 1 (2023): e0011019. https://doi.org/10.1371/journal.pntd.0011019.
MLA (9th ed.) CitationLA, Rodriguez Carnero, et al. "Anti-Trypanosoma Cruzi Antibody Profiling in Patients with Chagas Disease Treated with Benznidazole Assessed by Genome Phage Display." PLoS Neglected Tropical Diseases, vol. 17, no. 1, 2023, p. e0011019, https://doi.org/10.1371/journal.pntd.0011019.
